{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:20:21Z","timestamp":1793996421788,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA257961"],"award-info":[{"award-number":["R01CA257961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA207946"],"award-info":[{"award-number":["U01CA207946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","award":["P30 CA016058"],"award-info":[{"award-number":["P30 CA016058"]}],"id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.nano.2023.102667","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T07:02:50Z","timestamp":1679382170000},"page":"102667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Ligand-displaying-exosomes using RNA nanotechnology for targeted delivery of multi-specific drugs for liver cancer regression"],"prefix":"10.1016","volume":"50","author":[{"given":"Satheesh","family":"Ellipilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Binzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nano.2023.102667_bb0005","first-page":"141","article-title":"Update in global trends and aetiology of hepatocellular carcinoma","volume":"22","author":"Rawla","year":"2018","journal-title":"Journal"},{"issue":"3","key":"10.1016\/j.nano.2023.102667_bb0010","first-page":"266","article-title":"Hepatocellular carcinoma: management of an increasingly common problem","volume":"21","author":"Davis","year":"2008","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0015","first-page":"175","article-title":"Chapter 9 - drug excretion","author":"Taft","year":"2009","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0020","first-page":"173","article-title":"Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance","volume":"330","author":"Wang","year":"2021","journal-title":"Journal"},{"issue":"7","key":"10.1016\/j.nano.2023.102667_bb0025","first-page":"452","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0030","first-page":"256","article-title":"Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy","volume":"8","author":"Kim","year":"2017","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0035","first-page":"125","article-title":"Drug therapy for advanced-stage liver cancer","volume":"3","author":"Peck-Radosavljevic","year":"2014","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0040","first-page":"239","article-title":"Sorafenib","volume":"44","author":"Abdelgalil","year":"2019","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0045","first-page":"217","article-title":"5-Fluorouracil","volume":"26","year":"1981","journal-title":"Journal"},{"issue":"4","key":"10.1016\/j.nano.2023.102667_bb0050","first-page":"853","article-title":"An overview of doxorubicin formulations in cancer therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"Journal"},{"issue":"4","key":"10.1016\/j.nano.2023.102667_bb0055","first-page":"447","article-title":"Treatment of intermediate stage hepatocellular carcinoma: a review of intrahepatic doxorubicin drug-delivery systems","volume":"5","author":"Dubbelboer","year":"2014","journal-title":"Journal"},{"issue":"1\u20132","key":"10.1016\/j.nano.2023.102667_bb0060","first-page":"179","article-title":"Paclitaxel and its formulations","volume":"235","author":"Singla","year":"2002","journal-title":"Journal"},{"issue":"4","key":"10.1016\/j.nano.2023.102667_bb0065","first-page":"333","article-title":"Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges","volume":"26","author":"Singh","year":"2009","journal-title":"Journal"},{"issue":"1","key":"10.1016\/j.nano.2023.102667_bb0070","first-page":"972","article-title":"Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy","volume":"11","author":"Guo","year":"2020","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0075","first-page":"173","article-title":"Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance","volume":"330","author":"Wang","year":"2020","journal-title":"Journal"},{"issue":"10","key":"10.1016\/j.nano.2023.102667_bb0080","first-page":"1260","article-title":"Capecitabine in advanced hepatocellular carcinoma","volume":"48","author":"Murer","year":"2016","journal-title":"Journal"},{"issue":"12","key":"10.1016\/j.nano.2023.102667_bb0085","first-page":"1713","article-title":"Capecitabine in advanced hepatocellular carcinoma: a multicenter experience","volume":"51","author":"Pelizzaro","year":"2019","journal-title":"Journal"},{"issue":"33","key":"10.1016\/j.nano.2023.102667_bb0090","first-page":"5562","article-title":"Small molecular gemcitabine prodrugs for cancer therapy","volume":"27","author":"Miao","year":"2020","journal-title":"Journal"},{"issue":"3","key":"10.1016\/j.nano.2023.102667_bb0095","first-page":"400","article-title":"Tamoxifen: 25-year perspective","volume":"51","author":"Higa","year":"1994","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0100","first-page":"CD001024","article-title":"Tamoxifen for hepatocellular carcinoma","volume":"8","author":"Nowak","year":"2020","journal-title":"Journal"},{"issue":"9423","key":"10.1016\/j.nano.2023.102667_bb0105","first-page":"1802","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Journal"},{"issue":"27","key":"10.1016\/j.nano.2023.102667_bb0110","first-page":"44976","article-title":"Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis","volume":"8","author":"Cao","year":"2017","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0115","first-page":"44","article-title":"Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight","volume":"18","author":"Lohitesh","year":"2018","journal-title":"Journal"},{"issue":"1","key":"10.1016\/j.nano.2023.102667_bb0120","first-page":"23","article-title":"Current trends and challenges in cancer management and therapy using designer nanomaterials","volume":"6","author":"Navya","year":"2019","journal-title":"Journal"},{"issue":"3","key":"10.1016\/j.nano.2023.102667_bb0125","first-page":"782","article-title":"Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"Journal"},{"issue":"1","key":"10.1016\/j.nano.2023.102667_bb0130","first-page":"972","article-title":"Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy","volume":"11","author":"Guo","year":"2020","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0135","first-page":"524","article-title":"Rational design for controlled release of dicer-substrate siRNA harbored in phi29 pRNA-based nanoparticles","volume":"25","author":"Binzel","year":"2021","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0140","article-title":"The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development","volume":"186","author":"Li","year":"2022","journal-title":"Journal"},{"issue":"10","key":"10.1016\/j.nano.2023.102667_bb0145","first-page":"13180","article-title":"RNA nanoparticles as rubber for compelling vessel extravasation to enhance tumor targeting and for fast renal excretion to reduce toxicity","volume":"14","author":"Ghimire","year":"2020","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0150","first-page":"12","article-title":"Strategic design of extracellular vesicle drug delivery systems","volume":"130","author":"Armstrong","year":"2018","journal-title":"Journal"},{"issue":"1","key":"10.1016\/j.nano.2023.102667_bb0155","first-page":"585","article-title":"Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source","volume":"27","author":"Meng","year":"2020","journal-title":"Journal"},{"issue":"1","key":"10.1016\/j.nano.2023.102667_bb0160","first-page":"82","article-title":"Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression","volume":"13","author":"Pi","year":"2018","journal-title":"Journal"},{"issue":"6","key":"10.1016\/j.nano.2023.102667_bb0165","first-page":"1159","article-title":"Exploitation of exosomes as nanocarriers for gene-, chemo-, and immune-therapy of cancer","volume":"12","author":"Srivastava","year":"2016","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0170","first-page":"43","article-title":"Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping","volume":"311\u2013312","author":"Zheng","year":"2019","journal-title":"Journal"},{"issue":"5","key":"10.1016\/j.nano.2023.102667_bb0175","first-page":"364","article-title":"Non-small-cell lung cancer regression by siRNA delivered through exosomes that display EGFR RNA aptamer","volume":"31","author":"Li","year":"2021","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0180","first-page":"465","article-title":"hucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury","volume":"25","author":"Yan","year":"2017","journal-title":"Journal"},{"issue":"13","key":"10.1016\/j.nano.2023.102667_bb0185","first-page":"7082","article-title":"Application of mesenchymal stem cell exosomes and their drug-loading systems in acute liver failure","volume":"24","author":"Zhang","year":"2020","journal-title":"Journal"},{"issue":"9","key":"10.1016\/j.nano.2023.102667_bb0190","first-page":"3625","article-title":"Exosomes as a drug delivery system in cancer therapy: potential and challenges","volume":"15","author":"Kibria","year":"2018","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0195","first-page":"116","article-title":"Potential therapeutic applications of exosomes in different autoimmune diseases","volume":"205","author":"Xu","year":"2019","journal-title":"Journal"},{"issue":"6","key":"10.1016\/j.nano.2023.102667_bb0200","first-page":"6670","article-title":"Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders","volume":"13","author":"Riazifar","year":"2019","journal-title":"Journal"},{"issue":"1","key":"10.1016\/j.nano.2023.102667_bb0205","first-page":"14644","article-title":"Arrowtail RNA for ligand display on ginger exosome-like nanovesicles to systemic deliver siRNA for cancer suppression","volume":"8","author":"Li","year":"2018","journal-title":"Journal"},{"issue":"1","key":"10.1016\/j.nano.2023.102667_bb0210","first-page":"186","article-title":"Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent microRNA regulation agents","volume":"10","author":"Alhasan","year":"2014","journal-title":"Journal"},{"issue":"3","key":"10.1016\/j.nano.2023.102667_bb0215","first-page":"172","article-title":"Extracellular vesicles: unique intercellular delivery vehicles","volume":"27","author":"Maas","year":"2017","journal-title":"Journal"},{"issue":"4","key":"10.1016\/j.nano.2023.102667_bb0220","first-page":"218","article-title":"Exosomes and exosome-inspired vesicles for targeted drug delivery","volume":"10","author":"Antimisiaris","year":"2018","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0225","first-page":"80","article-title":"Engineered extracellular vesicles and their mimetics for clinical translation","volume":"177","author":"Kim","year":"2020","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0230","first-page":"536","article-title":"Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy","volume":"28","author":"Shi","year":"2020","journal-title":"Journal"},{"issue":"5","key":"10.1016\/j.nano.2023.102667_bb0235","first-page":"494","article-title":"Antitumor activities against hepatocellular carcinoma induced by bone marrow mesenchymal stem cells pulsed with tumor-derived exosomes","volume":"40","author":"Ma","year":"2008","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0240","first-page":"456","article-title":"Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro","volume":"64","author":"Rao","year":"2016","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0245","first-page":"9355","article-title":"Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate","volume":"15","author":"Shao","year":"2020","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0250","first-page":"585","article-title":"Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells","volume":"13","author":"Liang","year":"2018","journal-title":"Journal"},{"issue":"10","key":"10.1016\/j.nano.2023.102667_bb0255","first-page":"1777","article-title":"Surface functionalization of exosomes using click chemistry","volume":"25","author":"Smyth","year":"2014","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0260","first-page":"599","article-title":"Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: strategies and significance","volume":"326","author":"Salunkhe","year":"2020","journal-title":"Journal"},{"issue":"1","key":"10.1016\/j.nano.2023.102667_bb0265","first-page":"14644","article-title":"Arrowtail RNA for ligand display on ginger exosome-like nanovesicles to systemic deliver siRNA for cancer suppression","volume":"8","author":"Li","year":"2018","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0270","first-page":"204","article-title":"Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells","volume":"54","author":"Shu","year":"2011","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0275","first-page":"1142","article-title":"Advancement of the emerging field of RNA nanotechnology","volume":"11","author":"Jasinski","year":"2017","journal-title":"Journal"},{"issue":"13","key":"10.1016\/j.nano.2023.102667_bb0280","first-page":"7398","article-title":"Thermostability, tunability, and tenacity of RNA as rubbery anionic polymeric materials in nanotechnology and nanomedicine-specific cancer targeting with undetectable toxicity","volume":"121","author":"Binzel","year":"2021","journal-title":"Journal"},{"issue":"12","key":"10.1016\/j.nano.2023.102667_bb0285","first-page":"833","article-title":"The emerging field of RNA nanotechnology","volume":"5","author":"Guo","year":"2010","journal-title":"Journal"},{"issue":"5","key":"10.1016\/j.nano.2023.102667_bb0290","first-page":"631","article-title":"RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications","volume":"10","author":"Li","year":"2015","journal-title":"Journal"},{"issue":"10","key":"10.1016\/j.nano.2023.102667_bb0295","first-page":"658","article-title":"Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics","volume":"6","author":"Shu","year":"2011","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0300","first-page":"283","article-title":"Well-defined multivalent ligands for hepatocytes targeting via asialoglycoprotein receptor","volume":"28","author":"Huang","year":"2017","journal-title":"Journal"},{"issue":"3","key":"10.1016\/j.nano.2023.102667_bb0305","first-page":"591","article-title":"The asialoglycoprotein receptor: relationships between structure, function, and expression","volume":"75","author":"Stockert","year":"1995","journal-title":"Journal"},{"issue":"8","key":"10.1016\/j.nano.2023.102667_bb0310","first-page":"1360","article-title":"Capacity limits of asialoglycoprotein receptor-mediated liver targeting","volume":"9","author":"Bon","year":"2017","journal-title":"Journal"},{"issue":"40","key":"10.1016\/j.nano.2023.102667_bb0315","first-page":"3526","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties","volume":"28","author":"Coulouarn","year":"2009","journal-title":"Journal"},{"issue":"10","key":"10.1016\/j.nano.2023.102667_bb0320","first-page":"8339","article-title":"Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine","volume":"6","author":"Kishikawa","year":"2015","journal-title":"Journal"},{"issue":"9","key":"10.1016\/j.nano.2023.102667_bb0325","article-title":"Retraction: miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3","volume":"12","year":"2017","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0330","first-page":"160","article-title":"MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest","volume":"310","author":"Xu","year":"2011","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0335","first-page":"34","article-title":"miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt\/beta-catenin pathway","volume":"106","author":"Cao","year":"2019","journal-title":"Journal"},{"issue":"9","key":"10.1016\/j.nano.2023.102667_bb0340","first-page":"735","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Journal"},{"issue":"1","key":"10.1016\/j.nano.2023.102667_bb0345","first-page":"1324730","article-title":"Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells","volume":"6","author":"Zhu","year":"2017","journal-title":"Journal"},{"issue":"5","key":"10.1016\/j.nano.2023.102667_bb0350","first-page":"652","article-title":"In vitro immunotoxicity assessment of culture-derived extracellular vesicles in human monocytes","volume":"13","author":"Rosas","year":"2016","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0355","first-page":"35","article-title":"Use of a hollow fiber bioreactor to collect extracellular vesicles from cells in culture","volume":"1740","author":"Yan","year":"2018","journal-title":"Journal"},{"key":"10.1016\/j.nano.2023.102667_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","author":"Th\u00e9ry","year":"2006","journal-title":"Curr Protoc Cell Biol"},{"issue":"10","key":"10.1016\/j.nano.2023.102667_bb0365","first-page":"2123","article-title":"MicroRNA-122 overexpression promotes apoptosis and tumor suppressor gene expression induced by microcystin-leucine arginine in mouse liver","volume":"32","author":"Wang","year":"2022","journal-title":"Journal"},{"issue":"4","key":"10.1016\/j.nano.2023.102667_bb0370","first-page":"1715","article-title":"ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells","volume":"30","author":"Yuan","year":"2013","journal-title":"Journal"},{"issue":"2","key":"10.1016\/j.nano.2023.102667_bb0375","first-page":"L198","article-title":"Depletion of phagocytes in the reticuloendothelial system causes increased inflammation and mortality in rabbits with Pseudomonas aeruginosa pneumonia","volume":"296","author":"Kurahashi","year":"2009","journal-title":"Journal"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963423000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963423000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:18:57Z","timestamp":1761549537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963423000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":75,"alternative-id":["S1549963423000187"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2023.102667","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligand-displaying-exosomes using RNA nanotechnology for targeted delivery of multi-specific drugs for liver cancer regression","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2023.102667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102667"}}